Gut Microbiota Dysbiosis in Preeclampsia: Mechanisms, Biomarkers, and Probiotic‐Based Interventions
Mediators of Inflammation · 2025
DOI: 10.1155/mi/3010379 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mediators of Inflammation, 2025. Verfasst von Yefang Zhao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Xingtai People's Hospital, Affiliated Hospital of Hebei Medical University, Xingtai, Hebei, China. Hauptthemen laut MEDLINE: Pre-Eclampsia, Gastrointestinal Microbiome, Dysbiosis, Probiotics. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hebei Province Medical Science Research Key Project.
Abstract (Originalsprache)
Background
This study aimed to investigate the impact of fecal microbiota transplantation (FMT) on gut microbiota composition and serum inflammatory factors in a murine model.
Methods
Female C57BL/6J mice ( n = 60) were divided into four groups: control (Con), negative (Neg), normal transplantation (NT), and preeclampsia transplantation (PET). The Con group received no treatment, while the Neg, NT, and PET groups were administered a triple antibiotic regimen (ampicillin, neomycin sulfate, and metronidazole) for 14 days to deplete gut microbiota. Following antibiotic treatment, FMT was performed: the NT group received fecal microbiota from healthy pregnant women and the PET group received microbiota from severe preeclampsia patients. Fecal samples and serum were collected for 16S rRNA sequencing and inflammatory factor analysis, respectively.
Results
Significant differences in gut microbial composition were observed between the PET group and other groups, with enriched taxa such as Coprococcus , Bacillales , and Staphylococcus in the PET group. Conversely, taxa such as Helicobacter and Klebsiella were more abundant in the fecal microbiota of mice in the NT group. Furthermore, serum levels of lipopolysaccharide (LPS), tumor necrosis factor‐alpha (TNF‐α), and interleukin‐6 (IL‐6) were markedly elevated in the PET group compared to the control, negative, and NT groups. Transplantation with fecal bacteria from preeclampsia patients leads to significant alterations in gut microbiota composition and increased serum inflammatory factors levels in mice.
Conclusion
These findings provide insights into the relationship between gut microbiota and inflammatory processes in preeclampsia and underscore the potential therapeutic implications of FMT in modulating gut microbiota dysbiosis and inflammatory responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics, Xingtai People's Hospital, Affiliated Hospital of Hebei Medical University, Xingtai, Hebei, China.
- Department of Proctology, Xingtai People's Hospital, Affiliated Hospital of Hebei Medical University, Xingtai, Hebei, China.
- Department of Obstetrics and Gynecology, First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
- Cancer Laboratory, Xingtai People's Hospital, Affiliated Hospital of Hebei Medical University, Xingtai, Hebei, China.
ORCID-Profile: Hongzhen Zhang
Förderung
- Hebei Province Medical Science Research Key Project
Zitieren
APA
Zhao, Y., Wang, B., Wei, X., Liu, D., Wang, R., Ma, H., Qiao, Z., Kong, N., Feng, J., Cui, D., Hou, S., & Zhang, H. (2025). Gut Microbiota Dysbiosis in Preeclampsia: Mechanisms, Biomarkers, and Probiotic‐Based Interventions. Mediators of Inflammation. https://doi.org/10.1155/mi/3010379
Vancouver
Zhao Y, Wang B, Wei X, Liu D, Wang R, Ma H, et al. Gut Microbiota Dysbiosis in Preeclampsia: Mechanisms, Biomarkers, and Probiotic‐Based Interventions. Mediators of Inflammation. 2025. doi:10.1155/mi/3010379
BibTeX
@article{Zhao2025,
author = {Zhao, Yefang and Wang, Bingjie and Wei, Xujing and Liu, Dengxiang and Wang, Ruiping and Ma, Huashu and Qiao, Zongxu and Kong, Nana and Feng, Jinhui and Cui, Dan and Hou, Shaoke and Zhang, Hongzhen},
title = {Gut Microbiota Dysbiosis in Preeclampsia: Mechanisms, Biomarkers, and Probiotic‐Based Interventions},
journal = {Mediators of Inflammation},
year = {2025},
doi = {10.1155/mi/3010379}
}
EUVIMED